IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 28 filers reported holding IKENA ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,285,000 | -73.4% | 290,000 | -63.4% | 0.01% | -69.6% |
| Q1 2022 | $4,832,000 | -64.4% | 792,077 | -26.7% | 0.02% | -66.2% |
| Q4 2021 | $13,560,000 | -39.4% | 1,081,309 | -3.2% | 0.07% | -34.6% |
| Q3 2021 | $22,381,000 | +42.7% | 1,117,349 | 0.0% | 0.10% | +62.5% |
| Q2 2021 | $15,688,000 | -58.9% | 1,117,349 | -17.2% | 0.06% | -66.1% |
| Q1 2021 | $38,124,000 | – | 1,349,513 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |